Journal of labelled compounds and radiopharmaceuticals p. 595 - 605 (1996)
Update date:2022-09-26
Topics:
Waterhouse, Rikki N.
Collier, T. Lee
O'Brien
[123I]-1-(2-Hydroxyethyl)-4-(4-iodophenoxymethyl)piperidine has been prepared as a novel sigma receptor radioligand for tumour imaging by SPECT. This ligand was found to be selective in vitro for the sigma-1 receptor (Ki = 2.3 nM) when tested in a variety of neuroreceptor binding assays. The lipophilicity of this ligand is appropriate for crossing the blood/brain barrier (log P7.5 = 4.0). Radioiodination was accomplished by no-carrier- added iododestannylation using chloramine-T in acetic acid. The specific activity of the radiotracer >10,000 mCi/μmole. The radiochemical yield was 63-77% EOS and the radiochemical purity was >99%.
View MoreContact:+86-515-88356562
Address:No.2, West Daqing Road, Yancheng, Jiangsu, China
Contact:+31-24-3886056
Address:Binderskampweg 29 Unit 36
Shandong LuZhou Amino Acid Co., Ltd
Contact:86-539-2218025
Address:yishui economic and technical development zone zhenxing south road
Xi'an Unique Electronic and Chemical Co., Ltd.
Contact:+86-029-88238008
Address:1703# B BUILDING WEST ELECTRONIC ZONE, XI'AN, CHINA
Weifang Arylchem Chemical Co., LTD
Contact:86-536-5217866
Address:Development Zone, Shouguang, Shandong Province
Doi:10.1007/BF00903131
(1962)Doi:10.1016/0040-4039(96)01192-6
(1996)Doi:10.1021/jo960852a
(1996)Doi:10.1002/ejoc.201900185
(2019)Doi:10.1021/jacs.0c05917
(2020)Doi:10.1002/zaac.19966220906
(1996)